Hyojin Kim

6.0k total citations · 1 hit paper
178 papers, 4.3k citations indexed

About

Hyojin Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hyojin Kim has authored 178 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 38 papers in Surgery. Recurrent topics in Hyojin Kim's work include Lung Cancer Treatments and Mutations (36 papers), Cancer Genomics and Diagnostics (23 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Hyojin Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (36 papers), Cancer Genomics and Diagnostics (23 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Hyojin Kim collaborates with scholars based in South Korea, United States and China. Hyojin Kim's co-authors include Jin-Haeng Chung, Sung Yong Oh, Suee Lee, Sanghoon Jheon, Hyuk-Chan Kwon, Ho-June Lee, Jeff Settleman, Yi Cao, Pan Du and Guanglei Zhuang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hyojin Kim

169 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells

2014 438 citations Hyojin Kim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hyojin Kim South Korea	33	2.2k	1.6k	1.1k	978	731	178	4.3k
Angelo Sidoni Italy	32	1.2k 0.6×	962 0.6×	1.1k 1.0×	712 0.7×	765 1.0×	188	3.7k
Niels Willi Switzerland	24	1.7k 0.8×	1.7k 1.0×	1.5k 1.4×	623 0.6×	629 0.9×	45	4.7k
Megan L. Troxell United States	36	1.5k 0.7×	1.2k 0.7×	1.3k 1.2×	699 0.7×	655 0.9×	141	4.3k
Sarah Dry United States	47	2.4k 1.1×	2.3k 1.4×	1.3k 1.1×	598 0.6×	1.0k 1.4×	197	7.2k
Yoshiaki Inayama Japan	35	1.2k 0.5×	1.5k 0.9×	1.2k 1.1×	547 0.6×	1.0k 1.4×	194	3.9k
Benjamin Esterni France	32	2.2k 1.0×	683 0.4×	1.4k 1.3×	1.0k 1.0×	512 0.7×	75	4.4k
Janusz Ryś Poland	30	1.3k 0.6×	1.5k 0.9×	1.0k 0.9×	809 0.8×	835 1.1×	170	4.0k
Paul Cottu France	36	2.5k 1.2×	1.1k 0.7×	1.3k 1.1×	1.8k 1.9×	576 0.8×	233	5.1k
Ignacio Durán Spain	37	2.3k 1.1×	1.4k 0.8×	1.5k 1.4×	562 0.6×	1.6k 2.2×	206	4.8k
Nam Hoon Cho South Korea	38	1.3k 0.6×	1.2k 0.8×	1.8k 1.6×	991 1.0×	1.0k 1.4×	223	4.9k

Countries citing papers authored by Hyojin Kim

Since Specialization

Citations

This map shows the geographic impact of Hyojin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyojin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyojin Kim more than expected).

Fields of papers citing papers by Hyojin Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyojin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyojin Kim. The network helps show where Hyojin Kim may publish in the future.

Co-authorship network of co-authors of Hyojin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hyojin Kim. A scholar is included among the top collaborators of Hyojin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyojin Kim. Hyojin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hyojin, Seokhwi Kim, Sangjoon Choi, et al.. (2024). Clinical Validation of Artificial Intelligence–Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non–Small Cell Lung Cancer. JCO Precision Oncology. 8(8). e2300556–e2300556. 12 indexed citations

Park, Gahee, Jongchan Park, Jeanne Shen, et al.. (2023). Relationship between tumor microenvironment (TME)-based histomic TGFβ signature (TGFBs), stromal fibroblast recruitment, and exclusion of immune cells as immunotherapy resistance mechanisms.. Journal of Clinical Oncology. 41(16_suppl). 2585–2585. 1 indexed citations

Kim, Tae Jin & Hyojin Kim. (2023). Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness. Pharmaceuticals. 16(12). 1718–1718. 2 indexed citations

Kim, Hyojin, et al.. (2023). Clinical Application of Gamitaeeumjowee-tang for Overweight or Obese Hypothyroidism Patients: A Retrospective Chart Review. Journal of Korean Medicine for Obesity Research. 23(2). 78–85. 2 indexed citations

Kim, Kidong, Hyojin Kim, Yong Beom Kim, et al.. (2023). A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients. Obstetrics & Gynecology Science. 66(6). 537–544.

Ji, Sang Chun, Jaeseong Oh, Hyojin Kim, et al.. (2023). Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects. Alimentary Pharmacology & Therapeutics. 57(7). 763–772. 12 indexed citations

Kim, Hyojin, et al.. (2023). Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer. Biomedicines. 11(10). 2691–2691. 5 indexed citations

Kim, Kidong, Hyojin Kim, Yong Beom Kim, et al.. (2022). Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer. Journal of Gynecologic Oncology. 33(3). e27–e27. 4 indexed citations

Cho, Sung‐Woo, et al.. (2021). Development of High-Intensity Focused Ultrasound Therapy for Inferior Turbinate Hypertrophy. Clinical and Experimental Otorhinolaryngology. 15(2). 160–167. 1 indexed citations

10.

Ahn, Soomin, Ji Won Woo, Hyojin Kim, et al.. (2021). Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability. Journal of Breast Cancer. 24(3). 266–266. 14 indexed citations

11.

Jeong, Woo‐Jin, Yun Jung Bae, Hyojin Kim, et al.. (2020). MRI-Based Assessment of the Pharyngeal Constrictor Muscle as a Predictor of Surgical Margin after Transoral Robotic Surgery in HPV-Positive Tonsillar Cancer. American Journal of Neuroradiology. 41(12). 2320–2326. 5 indexed citations

12.

Lee, Young-Eun, Hyojin Kim, Ji‐Young Choe, et al.. (2019). Liquid-Based Cytology Features of Papillary Squamotransitional Cell Carcinoma of the Uterine Cervix. Journal of Pathology and Translational Medicine. 53(5). 341–344. 1 indexed citations

13.

Paik, Jin Ho, Ji‐Young Choe, Hyojin Kim, et al.. (2016). Clinicopathological categorization of Epstein–Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leukemia & lymphoma. 58(1). 53–63. 21 indexed citations

14.

Kwon, Hyuk-Chan, Sung Hyun Kim, Sung Yong Oh, et al.. (2012). Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 17(3). 216–222. 347 indexed citations

15.

Jeon, In‐Ho, Il‐Hyung Park, Woo‐Kie Min, et al.. (2009). An anatomic study on the junctura tendinum in the 4th intermetacarpal space and its clinical implication. Clinical Anatomy. 23(1). 56–60. 9 indexed citations

16.

Kim, Hyojin, Dongil Choi, Geum‐Youn Gwak, et al.. (2009). Evaluation of esophageal varices on liver computed tomography: Receiver operating characteristic analyses of the performance of radiologists and endoscopists. Journal of Gastroenterology and Hepatology. 24(9). 1534–1540. 37 indexed citations

17.

Kwon, Hyuk-Chan, Sung Yong Oh, Suee Lee, Sunghyun Kim, & Hyojin Kim. (2007). Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study. World Journal of Gastroenterology. 13(46). 6231–6231. 18 indexed citations

18.

Lee, Seungwon, et al.. (2006). Comparative Study on the Long-Term Effectiveness betweenCoblator- and Microdebrider-Assisted Partial Turbinoplasty. Korean Journal of Otorhinolaryngology-head and Neck Surgery. 49(5). 510–516. 2 indexed citations

19.

Kim, Hyojin, et al.. (2006). Clinical Features of Herpes Zoster according to Immune State. Linchuang pifuke zazhi. 44(2). 149–156. 2 indexed citations

20.

Kim, Kyoung‐Tae, Jin-Ho Kim, Hyuk-Chan Kwon, et al.. (2005). Clinical significance of chromosomal abnormality in multiple myeloma. The Korean Journal of Internal Medicine. 69(3). 304–312. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact